Hepatitis C mortality trends in San Francisco: can we reach elimination targets?

Mirzazadeh, Ali; Facente, Shelley N; Burk, Katie; Kahn, James G; Morris, Meghan D

Mirzazadeh, Ali; Facente, Shelley N; Burk, Katie; Kahn, James G; Morris, Meghan D.

Afiliação

Mirzazadeh A; Department of Epidemiology and Biostatistics, University of California, San Francisco; Institute for Global Health Sciences, University of California, San Francisco. Electronic address: Ali.Mirzazadeh@ucsf.edu.
Facente SN; Facente Consulting, San Francisco, CA; School of Public Health, University of California, Berkeley.
Burk K; Community Health Equity and Promotion Branch, San Francisco Department of Public Health, San Francisco, CA.
Kahn JG; Philip R Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco.
Morris MD; Department of Epidemiology and Biostatistics, University of California, San Francisco; Institute for Global Health Sciences, University of California, San Francisco; School of Public Health, University of California, Berkeley.

Ann Epidemiol ; 65: 59-64, 2022 01.

Article em En | MEDLINE | ID: mdl-34700016

Assuntos

Hepacivirus; Hepatite C; Negro ou Afro-Americano; Hepatite C/epidemiologia; Hispânico ou Latino; Humanos; Masculino; Pessoa de Meia-Idade; São Francisco/epidemiologia; Estados Unidos/epidemiologia

Palavras-chave

Hcv elimination targets; Hepatitis c; Mortality

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus Limite: Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Ann Epidemiol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google